<code id='671E56B89B'></code><style id='671E56B89B'></style>
    • <acronym id='671E56B89B'></acronym>
      <center id='671E56B89B'><center id='671E56B89B'><tfoot id='671E56B89B'></tfoot></center><abbr id='671E56B89B'><dir id='671E56B89B'><tfoot id='671E56B89B'></tfoot><noframes id='671E56B89B'>

    • <optgroup id='671E56B89B'><strike id='671E56B89B'><sup id='671E56B89B'></sup></strike><code id='671E56B89B'></code></optgroup>
        1. <b id='671E56B89B'><label id='671E56B89B'><select id='671E56B89B'><dt id='671E56B89B'><span id='671E56B89B'></span></dt></select></label></b><u id='671E56B89B'></u>
          <i id='671E56B89B'><strike id='671E56B89B'><tt id='671E56B89B'><pre id='671E56B89B'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:8672
          Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT
          Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

          WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

          Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

          advertisement

          Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more
          The Biogen Aduhelm mess could happen again
          The Biogen Aduhelm mess could happen again

          BiogenrecentlyannounceditwillceaseboththestudyandsaleofitsAlzheimer'sdrugAduhelm.JessicaRinaldi/TheB

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Johnson & Johnson sued for allegedly overpaying for workers' drugs

          ChrisO'Meara/APJohnson&Johnsonfacesaconsequentialnewclassactionlawsuit—notinitsroleasamanuf